Business & Operations Announcements

Huirui Electric's subsidiary, Ningbo Shengke, received a government subsidy of 3.2 million yuan. This subsidy is related to assets and is expected to positively impact the company's operating performance. The final accounting treatment will be confirmed by the audit firm. Investors are advised to be aware of investment risks.

Xuzhou Helen-Zhe Special Vehicle Co., Ltd. has received invention patent certificates from the National Intellectual Property Administration. These patents, related to cable recycling vehicles and aerial work platforms, have a 20-year term and are already in use. While not impacting short-term performance, they enhance the company's intellectual property system and core competitiveness.

Chongqing R&M Pharmaceutical Co., Ltd. announced it has received a Drug Registration Certificate from the NMPA for its Inhaled N-acetylcysteine Solution (3ml:0.3g). This approval is expected to expand the company's product line and enhance competitiveness. The company acknowledges potential market uncertainties due to policy, procurement, and environmental changes.

Shandong Xiantan Co., Ltd. reported July 2026 sales revenue of RMB 541.04 million and sales volume of 6,070 tons. This represents year-on-year increases of 5.89% and 1.80% respectively. The company attributes growth to its processed food products, with a warning about potential price volatility impacting future performance.

Zhongkuang Resources announced that its wholly-owned subsidiary, Jiangxi Zhongkuang Lithium, has completed temporary production suspension and maintenance for its lithium salt production lines. The "30,000 tons/year high-purity lithium salt" line resumed production on August 10, 2026, and the "35,000 tons/year high-purity lithium salt" line will gradually resume production in mid-August 2026.

Chenke Ming Food's subsidiary, Aksu Xingjiang Muge, reported July 2026 live pig sales of 77,000 head, a 53.90% month-on-month increase and an 83.84% year-on-year increase. Sales revenue reached 50.54 million yuan, up 66.65% MoM and 42.03% YoY. The company attributes these increases to adjusted sales strategies and increased production capacity.

This report details Shandong Yisheng's July 2026 sales performance for broiler chicks and breeder pigs. Broiler chick sales revenue increased significantly year-over-year due to strong market demand and price increases. Breeder pig sales volume and revenue decreased month-over-month due to factors like piglet age. The company warns of potential impacts from price volatility.

This report details the sales performance of commercial fat pigs for Beijing Da Bei Nong Technology Group Co., Ltd. in July 2026. The company sold 23.89 million pigs, generating 3.19 billion yuan in revenue, with a year-on-year sales volume decrease of 23.77% and a revenue decrease of 12.84%. The average selling price was 11.04 yuan per kilogram.

Shandong Yabo Technology Co., Ltd. announces its wholly-owned subsidiary, Zhongfu Kai New Energy Technology, signed an EPC contract for the Meihekou Ruoshi New Energy 50MW/100MWh frequency regulation energy storage power station project. The contract value is RMB 99.8 million, representing 34.05% of the company's 2025 audited revenue. The project is expected to positively impact future performance.

Shandong Minhe Animal Husbandry Co., Ltd. reported its July 2026 broiler chick sales. Sales volume was 28.7643 million chicks, a 3.99% year-on-year increase. Sales revenue reached 77.2876 million yuan, an 86.86% year-on-year increase. The revenue growth is attributed to low prices in the prior year due to a weak market.

Shenzhen Shiyida Technology Co., Ltd. announces a change in accounting policies based on the Ministry of Finance's "Accounting Standards Interpretation No. 20". This change, effective from January 1, 2026, will not materially impact the company's financial position or results. The board and audit committee have reviewed and approved the change.

Zhejiang Pro-Health Pharmaceutical Co., Ltd. announces its subsidiary has received a Drug Registration Certificate for Cinnarizine Sustained-Release Tablets from the NMPA. This approval, classifying the drug as a Category 3 chemical drug, is deemed equivalent to a generic consistency evaluation. The product is expected to enrich the company's pipeline and enhance market competitiveness.

Luoniushan Co., Ltd. reports July 2026 sales figures for its livestock business. Sales volume decreased month-on-month but increased year-on-year, while sales revenue saw mixed performance. The company attributes increased year-to-date sales volume to expanded production capacity. Risks related to market price fluctuations are highlighted.

This announcement provides an update on the production suspension and maintenance of Qingdao Guolin Technology Group's subsidiaries. Xinjiang Guolin has completed its maintenance and resumed production. Xinjiang Kai Lianjie's maintenance is also complete, and production has resumed. The company will dynamically adjust Xinjiang Guolin's resumption based on market conditions and customer maintenance schedules.

Chengdu振芯科技股份有限公司 announced receiving government subsidies totaling 12.525 million RMB. This amount represents 44.25% of the company's net profit attributable to shareholders in 2025. The subsidies are related to daily operations and will be recognized as "other income," expected to increase total profit in 2026. Investors are advised to note potential investment risks.

Ningxia Xiaoming Agribusiness reported July 2026 sales of 2,128.74 million eggs and revenue of 88.64 million RMB. Sales volume and revenue increased month-over-month and year-over-year due to high temperatures impacting hen productivity and strong demand. The company anticipates continued seasonal demand growth in August.

Anhui Hua Ren Health Pharmaceutical Co., Ltd. announces its wholly-owned subsidiary, Anhui Zheng Yao Pharmaceutical Technology Co., Ltd., has received a drug registration acceptance notice from the NMPA for Ferrous Succinate Tablets. This signifies the product has entered the review phase. The company anticipates no significant short-term impact on performance, advising investors to exercise caution.

Huadong Medicine's wholly-owned subsidiary, Sinclair Pharma, has obtained EU MDR CE certification for its novel non-animal derived chitosan medical aesthetic injection product, KIO015 (Kytogen® Defend). This grants market access in the EU and positions it as the first and only such product globally, enhancing Huadong's medical aesthetics portfolio.

Shenzhen Super-Micro Technology Co., Ltd. is changing its accounting policies in accordance with new regulations from the Ministry of Finance. This change, effective from January 1, 2026, is due to the issuance of "Accounting Standards Interpretation No. 20." The company states this is a regulatory requirement and will not materially impact its financial position or performance.

Hefei Lifu Pharmaceutical Co., Ltd. announces its products were selected for the 12th batch of national centralized drug procurement. This is expected to increase market share and enhance brand image. The final agreed procurement volume and contract details are yet to be determined, posing some uncertainty.

Hunan Xiangjia Animal Husbandry Co., Ltd. reported July 2026 live poultry sales of 4.0451 million birds and revenue of 79.6932 million yuan. This represents a month-on-month increase of 10.40% in sales volume and 6.21% in revenue, and a year-on-year increase of 9.11% in volume and 56.91% in revenue.

Hangzhou Star Air Appliances Co., Ltd. and its subsidiary Hangzhou Huajin Electronics Co., Ltd. have obtained multiple invention and utility model patent certificates. These patents will enhance the company's intellectual property protection system and core competitiveness in areas like terminals, starters, and protectors. The acquisition is not expected to significantly impact near-term operations.

Tangrenshen Group reported July 2026 hog sales volume of 402,300 head, a 14.42% year-over-year increase, and sales revenue of RMB 311.28 million, a 47.20% year-over-year decrease. The revenue decrease is attributed to market price fluctuations and adjustments in the company's product mix. The company also highlighted the systemic risk of hog price volatility.

Shenzhen Jinnong Technology Co., Ltd. reported July 2026 hog sales volume of 107,100 head, a 34.92% year-on-year increase. Sales revenue was RMB 73.68 million, a 23.83% year-on-year decrease. The company attributes sales volume growth to increased piglet sales and revenue growth to rising hog prices and a higher proportion of commercial hog sales.

Shandong Mining Machinery Group Co., Ltd. announces the completion of the deregistration of its wholly-owned subsidiary, Qingdao Daode Investment Co., Ltd. This deregistration will not affect the company's consolidated financial statements or overall business development. The company confirms no harm to shareholder interests.

Jiangsu Baichuan High-Tech Materials Co., Ltd. announces a change in accounting policies based on the Ministry of Finance's "Accounting Standards Interpretation No. 20". This change, effective from January 1, 2026, is not expected to materially impact the company's financial position or results. The board and audit committee have reviewed and approved the change.

Hainan Strait Shipping Co., Ltd. announced that its wholly-owned subsidiary received a government subsidy of RMB 102,580,000.00. This subsidy is related to revenue and represents 59.25% of the company's 2025 net profit attributable to shareholders. The company will recognize this as other income in 2026, positively impacting its operating performance.

This report details Jiangxi Zhengbang Technology's July 2026 hog sales. The company sold 817,600 hogs, a 14.18% decrease month-on-month and a 17.60% increase year-on-year. Sales revenue was RMB 587 million, down 6.18% MoM and 20.81% YoY. The average price for hogs (excluding piglets) was RMB 10.78/kg, up 11.42% MoM.

Tiankang Biology reported July 2026 live pig sales of 39.61 thousand heads, a 0.88% decrease month-on-month and a 27.45% increase year-on-year. Sales revenue was 393 million yuan, up 3.42% MoM and down 12.47% YoY. The increase in sales volume is attributed to the consolidation of Xinjiang Qiangdu Husbandry's data starting June 2026.

Jiangsu Jinzhi Technology Co., Ltd. announced it has won two projects: the "State Grid Shanghai Electric Power Company 2026 Power Grid Engineering Material Second Framework Agreement (Agreement Inventory) Public Bidding Procurement" project for RMB 16.085 million and the "Nanjing Municipal Public Security Bureau Lishui Branch Intelligent Transportation and Public Safety Video Surveillance Maintenance Services" project for RMB 57.5078 million. The total contract value is RMB 73.5928 million, representing 4.71% of the company's 2025 revenue.

China Merchants Shekou reports July 2026 sales of 42.29 sq. km and RMB 13.814 billion, with cumulative sales of 347.47 sq. km and RMB 110.059 billion for Jan-July. The company also acquired seven new land parcels across various cities, with details on area, floor area ratio, and payment amounts provided.

China Longyuan Power Group announced its July 2026 power generation data. Total consolidated power generation was 6,192,888 MWh, a 2.15% decrease year-on-year. Wind power generation decreased by 4.92%, while solar power generation increased by 6.10%. Cumulative generation for the year also saw a slight decrease.

Dongrui Stock reported July 2026 live pig sales of 130,800 head, generating 160 million yuan in sales revenue, a 5.23% increase month-on-month. The average selling price of commercial pigs was 12.81 yuan/kg, up 18.35% month-on-month. These unaudited figures are for investor reference.

China Rare Earth Group Resource Technology Co., Ltd. announces changes to its accounting policies effective January 1, 2026, in accordance with new regulations issued by the Ministry of Finance. These changes, related to accounting interpretations, are not expected to have a material impact on the company's financial position or results.

Tianjin Binhai Energy Development Co., Ltd. announces its subsidiary, Inner Mongolia Xiangfu New Energy Co., Ltd., will sign engineering construction contracts with related parties, Yanghu Engineering Technology Co., Ltd. and Yanghu Engineering Co., Ltd., totaling an estimated RMB 124.28 million. This constitutes a related party transaction but not a major asset restructuring. The transactions are expected to proceed after shareholder approval.

Gansu Nenghua Co., Ltd. announces that its wholly-owned subsidiary, Gansu Coal First Engineering Co., Ltd. ("Mei-Yi Company"), has won bids for engineering construction projects at the Jiulongchuan Coal Mine. The total contract value is RMB 88.9164 million. This constitutes a related party transaction as the client, Qingyang Coal Power, is a subsidiary of the controlling shareholder. The transaction is approved by the board and does not require shareholder approval.

Xinjiang International Industry Co., Ltd. announces a supplementary agreement to an EPC contract for an intelligent warehousing project by its subsidiary, Xinjiang Zhongyou Chemical Industry Group Co., Ltd. The contract value is adjusted to RMB 566.72 million, and the completion date is extended to December 30, 2027. This agreement does not require board or shareholder approval and is not expected to negatively impact the company's finances or operations.

This announcement reports the company's live pig sales performance for July 2026 and January-July 2026. In July, sales volume was 137,900 head, generating 204 million RMB in revenue, with an average price of 11.93 RMB/kg. The company also highlights risks related to market price fluctuations and animal epidemics in the industry.

This announcement details the litigation progress concerning important contracts for Shenzhen Yitian Automation Equipment Co., Ltd. The company is involved in two main cases: one with Jiangsu Chuangyue, resulting in a first-instance judgment for RMB 30.5 million, and another with Hebei Guangxing, where the execution phase has been terminated. The financial impact is being accounted for, with final confirmation pending auditor review.

Guangdong Taiankang Pharmaceutical Co., Ltd. announces its wholly-owned subsidiary, Shandong Huabokai Sheng Biotechnology Co., Ltd., has had its product, Baricitinib Tablets, selected in the 12th batch of national centralized drug procurement. This is expected to increase sales volume and market share, positively impacting future operating performance. The company will closely monitor subsequent developments.

Wenzhou Hongfeng Electric Alloy Co., Ltd. announces that its subsidiary, Wenzhou Hongfeng Alloy Co., Ltd., has received a utility model patent certificate from the State Intellectual Property Office. The patent is for a device for zinc melting and recovery of cemented carbide and grinding waste. The patent term is ten years, and it is expected to enhance the company's core competitiveness.

Di'a Co., Ltd. announces the addition of four new self-operated stores in July 2026, located in Dalian, Hangzhou, Zunyi, and Ganzhou. These stores, specializing in inlaid jewelry, represent an investment of approximately 550 million yuan. The company notes that these figures are preliminary and subject to change in future reports.

Zhejiang Tailin Bioengineering Co., Ltd. announces that its wholly-owned subsidiary, Zhejiang Tailin Medical Engineering Co., Ltd., has obtained one invention patent certificate. This patent is for a high-precision automatic mixing and dispensing device for radioactive drugs and its dispensing method. The acquisition is expected to enhance the company's intellectual property protection system and core competitiveness.

This announcement from PENG DING HOLDING (SHENZHEN) CO., LTD. provides a preliminary revenue report for July 2026. The company reported consolidated revenue of RMB 3,200.71 million, a 6.61% increase year-over-year. This report is based on preliminary unaudited figures.

Shandong Xinyie Chemical Co., Ltd. announces its subsidiary, Dongying Baomo Environmental Engineering Co., Ltd., has signed a framework procurement contract with Sinopec International Business Co., Ltd. for polyacrylamide II. The contract is for supply to four Sinopec oilfields and is valid until August 20, 2027. The company's financial impact is currently uncertain due to estimated volumes and allocation rules.

Zhejiang Weixing New Material Co., Ltd. announces a change in its accounting policies, effective January 1, 2026, in accordance with the Ministry of Finance's "Interpretation No. 20 of the Accounting Standards for Business Enterprises." This change, related to the assessment of financial asset contractual cash flow characteristics and accounting for monetary non-convertibility, is not expected to materially impact the company's financial position or performance.

Beijing Keli Electric Group Co., Ltd. announces the progress of canceling its second-level holding subsidiaries, Foshan Chuangqu and Zaoan Dong. The cancellation is to optimize resource allocation and reduce management costs. Foshan Chuangqu has completed its deregistration. This move will not significantly impact the company's financial status or future development.

Tianbang Food reports July 2026 live hog sales volume of 706,200 head and sales revenue of RMB 516.78 million. Year-to-date sales volume reached 4.59 million head with revenue of RMB 3.84 billion. The company also reported July hog slaughter volume of 135,120 head.

Shandong Dongfang Ocean Science & Technology Co., Ltd. announces its subsidiary, Mass Spectrometry Biotechnology Co., Ltd., has obtained a medical device registration certificate for its catecholamine metabolic spectrum testing kit. The product's market impact and contribution to the company's performance are currently uncertain, and investors are advised to be aware of investment risks.

Guangzhou Da An Gene Co., Ltd. announces that its wholly-owned subsidiary, Guangzhou Datase Bio-engineering Technology Co., Ltd., has obtained a medical device registration certificate from the National Medical Products Administration for its Alpha-fetoprotein (AFP) assay kit (chemiluminescence immunoassay). The product is for in vitro quantitative determination of AFP in serum or plasma, primarily for monitoring primary liver cancer treatment. The company notes that market development for this product is ongoing and subject to market demand uncertainties.